Quest Diagnostics Q2 2026 Earnings Preview
Seeking Alpha ·
Quest Diagnostics ( DGX ) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open. The consensus EPS Estimate is $2.82 (+7.6% Y/Y) and the consensus Revenue Estimate is $2.97B (+7.6% Y/Y).
AI 시장 분석
Market attention is focused ahead of Quest Diagnostics' Q2 2026 earnings release. This earnings preview is a crucial indicator to gauge the company's diagnostic testing revenue growth and cost structure efficiency. Investors should closely monitor margin changes in core business segments and whether the annual earnings guidance will be raised.
상승 영향
- Biotech — Increased demand for diagnostic testing and earnings expectations will improve investment sentiment across the healthcare and biotech sectors.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 70% · Bearish (Short) 30%
388 participants
Related News
- Anthropic Commits Tens of Billions to AMD Server Chips
- Northern Trust projects 9%-10% 2026 revenue growth with ~400 bps operating leverage amid Visa exchange gains
- Cal-Maine plans over 60% Prepared Foods capacity increase through 1H fiscal 2028 with $54M expansion
- Travel + Leisure expects $1.065B-$1.085B 2026 EBITDA as it targets $2.6B-$2.675B gross VOI sales following Yes& and Spinnaker deals
- Oklo stock jumps after Microsoft, Nvidia join $200M nuclear AI initiative
- GMI Cloud Announces Strategic Compute Collaboration With NVIDIA
